ARO BIOTHERAPEUTICS CO

Profile

Company Names

ARO BIOTHERAPEUTICS CO

Addresses

601 WALNUT STREET, SUITE 740, PHILADELPHIA, PA 19106

3675 MARKET STREET, SUITE 200, PHILADELPHIA, PA 19104

Phone Numbers

215-544-1175

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

2017

State Incorporated:

DELAWARE

Total Amount Raised:

$122,870,105.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2022-12-13 
$24,032,627.00 
$100,000,000.00 
$75,967,373.00 
Equity 
3
2020-12-21 
$90,337,478.00 
$90,337,478.00 
$0.00 
Equity 
2
2019-12-20 
$5,000,000.00 
$5,000,000.00 
$0.00 
Debt 
1
2019-03-29 
$3,500,000.00 
$4,900,000.00 
$1,400,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ELIZABETH 
 
ANDERSON 
DIRECTOR
MIDLAND BANCSHARES INC   |  REVOLUTION MEDICINES, INC.   |  ARO BIOTHERAPEUTICS CO   |  RECONNAISSANCE ENERGY AFRICA LTD   |  RECONNAISSANCE ENERGY AFRICA LTD.
SUSAN 
B 
DILLON 
EXECUTIVE OFFICER, DIRECTOR
ARO BIOTHERAPEUTICS CO
MITTIE 
 
DOYLE 
EXECUTIVE OFFICER
ARO BIOTHERAPEUTICS CO   |  SANTA ANA BIO, INC.
SAAN-CHIRAG 
 
GANDHI 
DIRECTOR
ARO BIOTHERAPEUTICS CO
SCOTT 
 
GREENBERG 
EXECUTIVE OFFICER
KCC ACQUISITION, LLC   |  BLACK FALCON GLOBAL MACRO FUND I, LP   |  ARS INVESTORS LLC   |  OCP AUTO RECON FUNDING LLC   |  WRIGHT INVESTORS SERVICE HOLDINGS, INC.   |  LINCOLNSHIRE OFFICE PARTNERS INVESTORS, LLC   |  EDHESIVE LLC   |  VERIFYME, INC.   |  PRECISION FERMENTATION, INC.   |  ARO BIOTHERAPEUTICS CO   |  STARSTOCK, INC.   |  24 WATTS, INC
DANIEL 
 
JANSE 
DIRECTOR
ARO BIOTHERAPEUTICS CO   |  TRIUMVIRA IMMUNOLOGICS INC.   |  WALKING FISH THERAPEUTICS, INC.   |  ENPLUSONE BIOSCIENCES INC.   |  GARUDA THERAPEUTICS, INC.
MARK 
 
LAURENZI 
EXECUTIVE OFFICER
ARO BIOTHERAPEUTICS CO
MARK 
V. 
LAURENZI 
EXECUTIVE OFFICER
ARO BIOTHERAPEUTICS CO
JESS 
 
LIFTON 
DIRECTOR
ARO BIOTHERAPEUTICS CO
CHRISTOPHER 
 
MIRABELLI 
DIRECTOR
THERACLONE SCIENCES, INC.   |  TREVENA INC   |  APOFORE CORP   |  SYNOVEX CORP   |  GALLEON PHARMACEUTICALS INC   |  PROTEOSTASIS THERAPEUTICS, INC.   |  LEAP THERAPEUTICS, INC.   |  ARO BIOTHERAPEUTICS CO
KARYN 
 
O-NEIL 
EXECUTIVE OFFICER, DIRECTOR
ARO BIOTHERAPEUTICS CO
BRUCE 
 
PEACOCK 
DIRECTOR
IKANO THERAPEUTICS INC.   |  OPHTHOTECH CORP.   |  INVISIBLE SENTINEL, INC.   |  PANOPTICA, INC.   |  CARMA THERAPEUTICS INC.   |  CARISMA THERAPEUTICS INC.   |  ARO BIOTHERAPEUTICS CO   |  WINDTREE THERAPEUTICS INC /DE/   |  INTERIUS BIOTHERAPEUTICS, INC.   |  VITTORIA BIOTHERAPEUTICS, INC.
KEVIN 
 
RAIDY 
DIRECTOR
SEMMA THERAPEUTICS, INC.   |  PLIANT THERAPEUTICS, INC.   |  COWEN HEALTHCARE INVESTMENTS III LP   |  CHI EF III LP   |  ESCIENT PHARMACEUTICALS INC   |  ARO BIOTHERAPEUTICS CO   |  COWEN HEALTHCARE INVESTMENTS IV LP   |  CHI EF IV LP   |  LATIGO BIOTHERAPEUTICS, INC.
MARTEN 
 
STEEN 
DIRECTOR
FERROKIN BIOSCIENCES INC   |  ULTRAGENYX PHARMACEUTICAL INC.   |  HEALTHCAP VI, L.P.   |  CORTENDO AB   |  VAXIN INC.   |  STRONGBRIDGE BIOPHARMA PLC   |  HEALTHCAP VII, L.P.   |  BIOCLIN THERAPEUTICS, INC.   |  RAINIER THERAPEUTICS, INC.   |  ARO BIOTHERAPEUTICS CO   |  MAHZI THERAPEUTICS INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-12-28
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-12-13 
2021-12-16
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-21 
2021-06-11
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-21 
2021-04-16
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-21 
2021-01-05
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-21 
2020-01-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2019-12-20 
2019-04-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2019-03-29 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#